XVII International AIDS Conference--Mexico City, August 3-8, 2008.  Metabolic complications and hepatitis co-infection. News from the International AIDS Conference.
Highleyman
Liz
L
D000069446:Atazanavir Sulfate; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced; D008659:Metabolic Diseases / Q000150:complications*; D008800:Mexico; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors
D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate